Evidence map›Paper›PMID 35380695›Full record

ArticleNucleic acids research2022

Sequence and tissue targeting specificity of ZFP36L2 reveals Elavl2 as a novel target with co-regulation potential.

Ian C Redmon, Matthew Ardizzone, Hilal Hekimoğlu, Breanne M Hatfield, Justin M Waldern, Abhishek Dey, Stephanie A Montgomery, Alain Laederach, Silvia B V Ramos

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Ian C RedmonBiochemistry and Biophysics Department, University of North Carolina, Chapel Hill, NC 27599, USA.
Matthew ArdizzoneBiochemistry and Biophysics Department, University of North Carolina, Chapel Hill, NC 27599, USA.
Hilal HekimoğluBiochemistry and Biophysics Department, University of North Carolina, Chapel Hill, NC 27599, USA.
Breanne M HatfieldChemistry Department, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Justin M WaldernBiology Department, University of North Carolina, Chapel Hill, NC 27599, USA.
Abhishek DeyBiology Department, University of North Carolina, Chapel Hill, NC 27599, USA.
Stephanie A MontgomeryDepartment of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC 27599, USA.
Alain LaederachBiology Department, University of North Carolina, Chapel Hill, NC 27599, USA.ORCID 0000-0002-5088-9907
Silvia B V RamosBiochemistry and Biophysics Department, University of North Carolina, Chapel Hill, NC 27599, USA.ORCID 0000-0001-7900-9806
University of North Carolina at Chapel Hill · US

Funding

Non-coding RNA structure change in Chronic Obstructive Pulmonary DiseaseR01HL111527 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Alain T Laederach, Kevin M Weeks · 2012 to 2026
$6.6M
Variant induced RNA structure change in human genetic diseaseR35GM140844 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LAEDERACH, ALAIN T · 2021 to 2025
$2.1M
NHLBI NIH HHS R01 HL111527NIGMS NIH HHS R35 GM140844
6 · The paper itself

Abstract

Zinc finger protein 36 like 2 (ZFP36L2) is an RNA-binding protein that destabilizes transcripts containing adenine-uridine rich elements (AREs). The overlap between ZFP36L2 targets in different tissues is minimal, suggesting that ZFP36L2-targeting is highly tissue specific. We developed a novel Zfp36l2-lacking mouse model (L2-fKO) to identify factors governing this tissue specificity. We found 549 upregulated genes in the L2-fKO spleen by RNA-seq. These upregulated genes were enriched in ARE motifs in the 3'UTRs, which suggests that they are ZFP36L2 targets, however the precise sequence requirement for targeting was not evident from motif analysis alone. We therefore used gel-shift mobility assays on 12 novel putative targets and established that ZFP36L2 requires a 7-mer (UAUUUAU) motif to bind. We observed a statistically significant enrichment of 7-mer ARE motifs in upregulated genes and determined that ZFP36L2 targets are enriched for multiple 7-mer motifs. Elavl2 mRNA, which has three 7-mer (UAUUUAU) motifs, was also upregulated in L2-fKO spleens. Overexpression of ZFP36L2, but not a ZFP36L2(C176S) mutant, reduced Elavl2 mRNA expression, suggesting a direct negative effect. Additionally, a reporter assay demonstrated that the ZFP36L2 effect on Elavl2 decay is dependent on the Elavl2-3'UTR and requires the 7-mer AREs. Our data indicate that Elavl2 mRNA is a novel target of ZFP36L2, specific to the spleen. Likely, ZFP36L2 combined with other RNA binding proteins, such as ELAVL2, governs tissue specificity.

Indexed as

ELAV-Like Protein 2RNA-Binding Proteins3' Untranslated RegionsAnimalsMiceOrgan SpecificityRNA, MessengerRNA-SeqTristetraprolin3' Untranslated RegionsElavl2 protein, mouseELAV-Like Protein 2RNA-Binding ProteinsRNA, MessengerTristetraprolinZfp36 protein, mouse

Identifiers

PMID35380695
PMCPMC9023260
OpenAlexW4224320980

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.